AAAAAA

   
Results: 1-15 |
Results: 15

Authors: BORZAK S TISDALE JE AMIN NB GOLDBERG AD FRANK D PADHI ID HIGGINS RSD
Citation: S. Borzak et al., ATRIAL-FIBRILLATION AFTER BYPASS-SURGERY - DOES THE ARRHYTHMIA OR THECHARACTERISTICS OF THE PATIENTS PROLONG HOSPITAL STAY, Chest, 113(6), 1998, pp. 1489-1491

Authors: SHARMA ND ROSMAN HS PADHI ID TISDALE JE
Citation: Nd. Sharma et al., TORSADES-DE-POINTES ASSOCIATED WITH INTRAVENOUS HALOPERIDOL IN CRITICALLY ILL PATIENTS, The American journal of cardiology, 81(2), 1998, pp. 238-240

Authors: TISDALE JE PADHI ID GOLDBERG AD SILVERMAN NA WEBB CR HIGGINS RSD PAONE G FRANK DM BORZAK S
Citation: Je. Tisdale et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS DILTIAZEM AND DIGOXIN FOR ATRIAL-FIBRILLATION AFTER CORONARY-ARTERY BYPASS-SURGERY, The American heart journal, 135(5), 1998, pp. 739-747

Authors: SHARMA ND ROSMAN HS PADHI ID TISDALE JE
Citation: Nd. Sharma et al., TORSADES-DE-POINTES ASSOCIATED WITH INTRAVENOUS HALOPERIDOL IN CRITICALLY ILL PATIENTS - INCIDENCE AND INFLUENCE ON LENGTH OF HOSPITAL STAY, Journal of the American College of Cardiology, 29(2), 1997, pp. 14133-14133

Authors: PADHI ID LONG P BASHA M ANANDAN JV
Citation: Id. Padhi et al., INTERACTION BETWEEN TACROLIMUS AND ERYTHROMYCIN, Therapeutic drug monitoring, 19(1), 1997, pp. 120-122

Authors: BORZAK S TISDALE JE AMIN NB GOLDBERG AD WEBB CR PADHI ID FRANK DM JACOBSEN G PAONE G HIGGINS RSD SILVERMAN NA
Citation: S. Borzak et al., ATRIAL-FIBRILLATION AFTER BYPASS-SURGERY - DOES THE ARRHYTHMIA OR THECHARACTERISTICS OF THE PATIENTS PROLONG HOSPITAL STAY, Circulation, 96(8), 1997, pp. 3445-3445

Authors: SHARMA N ROSMAN H PADHI ID TISDALE JE
Citation: N. Sharma et al., QTC INTERVAL PROLONGATION AND TORSADES-DE-POINTES ASSOCIATED WITH INTRAVENOUS HALOPERIDOL - A CASE-CONTROL STUDY, Journal of investigative medicine, 44(3), 1996, pp. 210-210

Authors: TISDALE JE PADHI ID WARE JA SVENSSON CK
Citation: Je. Tisdale et al., COMPARISON OF FLUORESCENCE POLARIZATION IMMUNOASSAY WITH LIQUID-CHROMATOGRAPHY FOR QUANTIFICATION OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN URINE, Therapeutic drug monitoring, 18(6), 1996, pp. 693-697

Authors: TISDALE JE RUDIS MI PADHI ID BORZAK S SVENSSON CK WEBB CR ACCIAIOLI J WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., DISPOSITION OF PROCAINAMIDE IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE RECEIVING MEDICAL THERAPY, Journal of clinical pharmacology, 36(1), 1996, pp. 35-41

Authors: TISDALE JE PADHI ID WARE JA SVENSSON CK
Citation: Je. Tisdale et al., FLUORESCENCE POLARIZATION IMMUNOASSAY (F) FOR QUANTIFICATION OF PROCAINAMIDE (PA) AND N-ACETYL-PROCAINAMIDE (NAPA) IN URINE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 103-103

Authors: TISDALE JE PADHI ID GOLDBERG AD SILVERMAN NA WEBB CR HIGGINS RS PAONE G FRANK DM BORZAK S
Citation: Je. Tisdale et al., DILTIAZEM CONTROLS VENTRICULAR RATE MORE RAPIDLY BUT NOT MORE EFFECTIVELY THAN DIGOXIN IN PATIENTS WITH ATRIAL-FIBRILLATION FOLLOWING CORONARY-ARTERY BYPASS-SURGERY, Circulation, 94(8), 1996, pp. 1103-1103

Authors: TISDALE JE PADHI ID SHARMA ND ROSMAN H
Citation: Je. Tisdale et al., INTRAVENOUS HALOPERIDOL PROLONGS QTC INTERVAL AND INCREASES QT INTERVAL DISPERSION IN CRITICALLY ILL PATIENTS, Circulation, 94(8), 1996, pp. 1432-1432

Authors: TISDALE JE RUDIS MI PADHI ID SVENSSON CK WEBB CR BORZAK S WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., INHIBITION OF N-ACETYLATION OF PROCAINAMIDE AND RENAL CLEARANCE OF N-ACETYLPROCAINAMIDE BY PARA-AMINOBENZOIC ACID IN HUMANS, Journal of clinical pharmacology, 35(9), 1995, pp. 902-910

Authors: TISDALE JE RUDIS MI PADHI ID BORZAK S SVENSSON CK WEBB CR WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., PROCAINAMIDE (PA) PHARMACOKINETICS IN CONGESTIVE-HEART-FAILURE (CHF), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 142-142

Authors: TISDALE JE RUDIS MI PADHI ID SVENSSON CK WEBB CR BORZAK S WARE JA KREPOSTMAN A ZAROWITZ BJ
Citation: Je. Tisdale et al., INHIBITION OF PROCAINAMIDE (PA) N-ACETYLATION BY PARA-AMINOBENZOIC ACID (PABA), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 184-184
Risultati: 1-15 |